A mid-sized global biotechnology company partnered with Caidya to support its oncology clinical portfolio, including multiple Phase 1A and 1B studies across various countries. The collaboration covered data management, clinical programming, global clinical analytics, and project management.
The company aimed to improve operational efficiency, enhance data quality, and strengthen communication to accelerate timelines and ensure regulatory compliance.
Caidya’s role was to provide a unified, strategic approach to managing complex clinical activities while remaining adaptable to changing study needs.
Explore our news and updates as we deliver a superior customer experience.
News
12/19/2025
News
11/20/2025
News
09/19/2025